End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
24.85 CNY | -0.52% | -6.89% | +8.80% |
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Revenues | 1.65B | 2.45B | 4.59B | 3.65B | 2.17B | |
Other Revenues, Total | 15.58M | 16.38M | 28.07M | 31.39M | 6.52M | |
Total Revenues | 1.66B | 2.46B | 4.62B | 3.68B | 2.18B | |
Cost of Goods Sold, Total | 496M | 760M | 1.39B | 1.12B | 692M | |
Gross Profit | 1.17B | 1.7B | 3.24B | 2.57B | 1.49B | |
Selling General & Admin Expenses, Total | 779M | 836M | 1.34B | 1.55B | 1.36B | |
Provision for Bad Debts | 1.46M | 3.27M | 2.02M | -3.7M | 7.52M | |
R&D Expenses | 12.96M | 16.8M | 16.82M | 17.94M | 21.72M | |
Other Operating Expenses | 98.7M | 172M | 288M | 219M | 136M | |
Other Operating Expenses, Total | 892M | 1.03B | 1.64B | 1.79B | 1.52B | |
Operating Income | 276M | 676M | 1.59B | 779M | -33.67M | |
Interest Expense, Total | - | - | -12.33M | -23.83M | -22.15M | |
Interest And Investment Income | 12.07M | 18.61M | 49.47M | 111M | 210M | |
Net Interest Expenses | 12.07M | 18.61M | 37.14M | 87.09M | 188M | |
Currency Exchange Gains (Loss) | -1.22M | 8.6K | 719K | -1.55M | -1.38M | |
Other Non Operating Income (Expenses) | -8.98M | -16.5M | -22.51M | -25.66M | -46.25M | |
EBT, Excl. Unusual Items | 278M | 678M | 1.61B | 839M | 106M | |
Gain (Loss) On Sale Of Investments | - | 6.03M | 17.57M | 39.29M | 31.15M | |
Gain (Loss) On Sale Of Assets | -1.2K | -417K | -733K | 1.24M | 19.71M | |
Asset Writedown | -13 | -4 | -5.41M | -18.5M | -56.74M | |
Other Unusual Items | 12.26M | 7.85M | 10.27M | 24.06M | 12.41M | |
EBT, Incl. Unusual Items | 290M | 692M | 1.63B | 885M | 113M | |
Income Tax Expense | 26.13M | 128M | 330M | 156M | 43.87M | |
Earnings From Continuing Operations | 264M | 563M | 1.3B | 729M | 68.96M | |
Net Income to Company | 264M | 563M | 1.3B | 729M | 68.96M | |
Minority Interest | - | 54.14K | 10.61K | - | - | |
Net Income - (IS) | 264M | 563M | 1.3B | 729M | 68.96M | |
Net Income to Common Incl Extra Items | 264M | 563M | 1.3B | 729M | 68.96M | |
Net Income to Common Excl. Extra Items | 264M | 563M | 1.3B | 729M | 68.96M | |
Per Share Items | ||||||
Net EPS - Basic | 0.73 | 1.56 | 3.62 | 1.82 | 0.17 | |
Basic EPS - Continuing Operations | 0.73 | 1.56 | 3.62 | 1.82 | 0.17 | |
Basic Weighted Average Shares Outstanding | 362M | 361M | 360M | 401M | 406M | |
Net EPS - Diluted | 0.73 | 1.56 | 3.62 | 1.82 | 0.17 | |
Diluted EPS - Continuing Operations | 0.73 | 1.56 | 3.62 | 1.82 | 0.17 | |
Diluted Weighted Average Shares Outstanding | 362M | 361M | 360M | 401M | 406M | |
Normalized Basic EPS | 0.48 | 1.17 | 2.8 | 1.31 | 0.16 | |
Normalized Diluted EPS | 0.48 | 1.17 | 2.8 | 1.31 | 0.16 | |
Dividend Per Share | - | - | 2 | 1 | 0.5 | |
Payout Ratio | 34.1 | 21.3 | - | 109.76 | 592.84 | |
Supplemental Items | ||||||
EBITDA | 324M | 723M | 1.6B | 783M | -27.32M | |
EBITA | 276M | 676M | 1.59B | 779M | -33.33M | |
EBIT | 276M | 676M | 1.59B | 779M | -33.67M | |
EBITDAR | - | - | 1.68B | 821M | -20.89M | |
Total Revenues (As Reported) | 1.66B | 2.46B | 4.62B | 3.68B | 2.18B | |
Effective Tax Rate - (Ratio) | 9.01 | 18.57 | 20.22 | 17.64 | 38.88 | |
Total Current Taxes | - | - | 326M | 155M | 45.09M | |
Total Deferred Taxes | - | - | 4.31M | 722K | -1.22M | |
Normalized Net Income | 174M | 424M | 1.01B | 525M | 66.44M | |
Interest on Long-Term Debt | - | - | 12.33M | 21.54M | 14.96M | |
Supplemental Operating Expense Items | ||||||
Marketing Expenses | 138M | 137M | 307M | 342M | 208M | |
Selling and Marketing Expenses | 674M | 729M | 1.14B | 1.38B | 1.22B | |
General and Administrative Expenses | 105M | 107M | 118M | 130M | 127M | |
Research And Development Expense From Footnotes | 12.96M | 16.8M | 16.82M | 17.94M | 21.72M | |
Net Rental Expense, Total | - | - | 80.85M | 37.37M | 6.43M | |
Imputed Operating Lease Interest Expense | - | - | - | 9.55M | 1.33M | |
Imputed Operating Lease Depreciation | - | - | - | 27.83M | 5.1M | |
Stock-Based Comp., G&A Exp. (Total) | 5.14M | 9.65M | 4.09M | 561K | 187K | |
Total Stock-Based Compensation | 5.14M | 9.65M | 4.09M | 561K | 187K |